Mabwell (Shanghai) Bioscience Co., Ltd.

Shanghai biotech developing and selling antibody drugs and ADC cancer therapies

What Mabwell does

Mabwell is a Chinese biopharmaceutical company that researches, makes, and sells biologic medicines. It already markets drugs for bone tumors, osteoporosis, low white blood cell counts, and autoimmune diseases. It is also developing new treatments for cancer, lung disease, eye disease, and blood disorders.

How Mabwell makes money

It earns revenue from selling its approved biologic drugs in China and internationally. It also invests in a pipeline of clinical-stage drug candidates that could bring in future product sales.

Products & services

• MAIWEIJIAN (giant cell tumor of bone)
• MALISHU (postmenopausal osteoporosis)
• MAILISHENG (albipagrastim alfa injection)
• JUNMAIKANG (adalimumab biosimilar)
• 9MW2821 (Nectin-4 ADC, Phase III)
• 9MW0211 (anti-VEGF antibody, Phase III)